雲意電氣(300304.SZ):子公司芯源誠達積極研發汽車尾氣系統的“心臟”產品氮氧傳感器
格隆匯12月5日丨雲意電氣(300304.SZ)近期在接待機構投資者調研時表示,公司子公司芯源誠達積極研發汽車尾氣系統的“心臟”產品氮氧傳感器,該產品通過利用陶瓷芯片的電化學反應,將成分複雜的高温尾氣中NOX的含量經過算法計算,轉換數字信號,和ECU實時通訊,具有較高的技術壁壘;公司現已突破國外技術封鎖,掌握陶瓷芯高温共燒技術和底層控制算法及芯片開發技術,同時高度整合產業鏈,國產替代進程加快。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.